MedPath

Performance of Acceleromyography With and Without Preload

Phase 4
Completed
Conditions
Neuromuscular Blockade
Interventions
Device: Hand Adapter (Organon, Oss, the Netherlands)
Device: Placebo
Registration Number
NCT00226018
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

The purpose of this study is to examine the precision, bias and limits of agreement when monitoring the neuromuscular block with acceleromyography with and without preload and compare the method to the gold standard, mechanomyography.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • ASA I-III
  • General anesthesia > 1 hour
  • Surgery under supine position with possibility of monitoring the neuromuscular block in both arms (thumbs)
  • Written informed content
Exclusion Criteria
  • Neuromuscular disorders, hepatic and renal dysfunction
  • Medication expected to interfere with the neuromuscular blocking agent
  • Allergy to any medication used during anesthesia
  • Body weight less or exceeding 20% of the ideal body weight
  • Pregnancy or breastfeeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Hand Adapter (Organon, Oss, the Netherlands)Acceleromyography with Hand Adapter on dominant arm
2Hand Adapter (Organon, Oss, the Netherlands)Acceleromyography with Hand Adapter on non-dominant arm
3PlaceboAcceleromyography without Hand Adapter on dominant arm
4PlaceboAcceleromygraphy without Hand Adapter on non-dominant arm
Primary Outcome Measures
NameTimeMethod
The precision of acceleromyography with and without preload during recovery
Secondary Outcome Measures
NameTimeMethod
Bias and limits of agreement for acceleromyography (AMG) with and without preload compared to mechanomyography (MMG) during recovery
All the following outcomes obtained with AMG with and without preload are compared to MMG. Furthermore the responses are compared when the AMG-values are "normalized":
Bias og limits of agreement between control TOF
Onset time
Time to reappearance of T1, T2, T3 and T4
Twitch height of T1 at reappearance of T1, T2, T3 and T4
Time to T1=25%
Interval 25-75%
Time to TOF-ratio = 0.9 and 1.0
Time to final T1
Time to final TOF ratio

Trial Locations

Locations (1)

Dep. of anesthesia, HOC, Rigshospitalet

🇩🇰

Copenhagen, Copenhagen Ø, Denmark

© Copyright 2025. All Rights Reserved by MedPath